DEIRDRE WAHL: Open Payments
NPI 1700366192 · FULTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 44 payments from 12 companies in 2025. Trend: 2023 $602 · 2024 $983 · 2025 $899
Food & beverage: $849Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $232 |
| AstraZeneca Pharmaceuticals LP | 10 | $161 |
| Abbott Laboratories | 3 | $93 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| Phathom Pharmaceuticals, Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $62 |
| Novo Nordisk Inc | 3 | $58 |
| Insulet Corporation | 1 | $32 |
| Amgen Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $28 |
Products named: VRAYLAR, AIRSUPRA, TRELEGY ELLIPTA, VOQUEZNA, JARDIANCE, FREESTYLE INSULINX, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
